322 related articles for article (PubMed ID: 23554313)
1. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
[TBL] [Abstract][Full Text] [Related]
2. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.
Chewning JH; Gudme CN; Hsu KC; Selvakumar A; Dupont B
J Immunol; 2007 Jul; 179(2):854-68. PubMed ID: 17617576
[TBL] [Abstract][Full Text] [Related]
3. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
[TBL] [Abstract][Full Text] [Related]
4. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
Front Immunol; 2019; 10():734. PubMed ID: 31024561
[TBL] [Abstract][Full Text] [Related]
5. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
6. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
7. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.
Fauriat C; Ivarsson MA; Ljunggren HG; Malmberg KJ; Michaëlsson J
Blood; 2010 Feb; 115(6):1166-74. PubMed ID: 19903900
[TBL] [Abstract][Full Text] [Related]
8. KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.
Hanvesakul R; Kubal C; Moore J; Neil D; Cook M; Ball S; Briggs D; Moss P; Cockwell P
PLoS One; 2011; 6(8):e23631. PubMed ID: 21912600
[TBL] [Abstract][Full Text] [Related]
9. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.
Yu J; Venstrom JM; Liu XR; Pring J; Hasan RS; O'Reilly RJ; Hsu KC
Blood; 2009 Apr; 113(16):3875-84. PubMed ID: 19179302
[TBL] [Abstract][Full Text] [Related]
10. Expression of KIR2DS1 does not significantly contribute to NK cell cytotoxicity in HLA-C1/C2 heterozygous haplotype B donors.
Baltner K; Kübler A; Pal M; Balvociute M; Mezger M; Handgretinger R; André MC
Int Immunol; 2017 Nov; 29(9):423-429. PubMed ID: 29099970
[TBL] [Abstract][Full Text] [Related]
11. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
12. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
[TBL] [Abstract][Full Text] [Related]
13. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.
Fischer JC; Ottinger H; Ferencik S; Sribar M; Punzel M; Beelen DW; Schwan MA; Grosse-Wilde H; Wernet P; Uhrberg M
J Immunol; 2007 Mar; 178(6):3918-23. PubMed ID: 17339492
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.
Sivori S; Carlomagno S; Falco M; Romeo E; Moretta L; Moretta A
Blood; 2011 Apr; 117(16):4284-92. PubMed ID: 21355085
[TBL] [Abstract][Full Text] [Related]
15. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I.
Moesta AK; Graef T; Abi-Rached L; Older Aguilar AM; Guethlein LA; Parham P
J Immunol; 2010 Oct; 185(7):4233-7. PubMed ID: 20802150
[TBL] [Abstract][Full Text] [Related]
16. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
[TBL] [Abstract][Full Text] [Related]
17. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.
Mancusi A; Ruggeri L; Urbani E; Pierini A; Massei MS; Carotti A; Terenzi A; Falzetti F; Tosti A; Topini F; Bozza S; Romani L; Tognellini R; Stern M; Aversa F; Martelli MF; Velardi A
Blood; 2015 May; 125(20):3173-82. PubMed ID: 25769621
[TBL] [Abstract][Full Text] [Related]
18. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.
Ashouri E; Rajalingam K; Barani S; Farjadian S; Ghaderi A; Rajalingam R
Sci Rep; 2021 Apr; 11(1):7932. PubMed ID: 33846431
[TBL] [Abstract][Full Text] [Related]
20. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.
Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O
J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
